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Stimulation of precursors of antibody-forming cells to divide and differentiate into 
cells actively synthesizing and secreting antibody is initiated by interactions among 
precursor cells, antigen, and lymphocytes derived from the thymus (1-6). The clonal 
selection  theory postulates  that  precursor  cells are  precommitted  to  respond  to  a 
limited range  of  antigenic specificities and  that recognition of  these  specificities is 
mediated through surface antigen receptors (7-10). 
Lymphocytes from several species have been shown by different techniques to have 
immunoglobulin molecules on their cell surfaces (11-28). Lymphocytes also have been 
shown to bind antigen specifically, presumably through these surface immunoglobulins 
(29-44). In the mouse, both the precursor cells and antigen-binding lymphocytes can 
be derived from bone marrow (41); these cells appear to be functional homologues of 
bursa-derived lymphocytes in birds (45).  It is these nonthymus-derived lymphocytes 
which  are the main source of lymphocytes with detectable surface imrnunoglobulin 
(25-27)  which is largely of  the 3'M  class in normal animals (17,  35); but immuno- 
globulins of other classes have also been detected (11,  12, 25-27). The immunoglobulin 
on cell surfaces is thought to be representative of the antibody to be secreted later by 
that cell both in terms of its specificity and immunoglobulin class (29,  32, 38, 42,  44, 
46-48). 
Precursors of antibody-forming cells, then,  are believed to  have  immunoglobulin 
receptors on their cell membranes which are antigen-specific and representative of the 
immunoglobulin class of the antibody to be later secreted by that cell. The combina- 
tion of antigen with  these  specific antibody-like receptors and  the  collaboration of 
thymus-derived lymphocytes results in  stimulation of  the  precursor cells into  cells 
actively secreting antibody (46).  One might predict that saturation of receptors of a 
given immunoglobulin class with a specific antiglobulin would suppress production of 
antibodies  of  only  that  immunoglobulin  class  after  antigenic  stimulation,  if  this 
"receptor  =  product" hypothesis is correct (48). 
It has been shown  that antibody to mouse K-chain (49), to mouse immunoglobulin, 
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to Fab of 3%, and to IgM inhibited primary 3'M responses in vitro under conditions 
which did not permit detection of antibody-forming cells of  other immunoglobulin 
classes  (42,  50).  Antibody to mouse immunoglobulin in tissue culture similarly in- 
hibited antibody production and the induction of tolerance to polymerized flageUin 
(51). 
The present studies investigated the effects of specific goat anti-mouse glob- 
ulins on primary immunoglobulin  (Ig) 1 class-specific plaque-forming cell (PFC) 
responses  in mouse  spleen cell cultures. A  recently developed technique was 
used which permits the detection of primary PFC responses of ~/G and ~/A, as 
well as 7M Ig classes in vitro (52). The data show that anti-3'1 or anti-'}~2 each 
suppressed both the 71 and ~'2, but not 7M or ~/A PFC responses, anti-TA sup- 
pressed  only the 7A  response, but antibody to/z-chain  suppressed  PFC  re- 
sponses  in  all  Ig  classes.  The  results  are  discussed in  terms  of  the  possible 
relationships between surface Ig receptors and the antibody ultimately secreted. 
Materials and Methods 
Animals.--C57BL/6,  AKR, and C3H/He male mice, 2-4 months old (Jackson Labora- 
tories, Bar Harbor, Maine), and BALB/c AnN male mice and New Zealand white male rabbits, 
3-6 months old, from the NIH DRS Rodent and Rabbit Production Section, were maintained 
on the appropriate laboratory chow and water ad libltum. Goats were maintained on a standard 
diet at the NIH Ungulate Division. 
Erythrocyte  Antigens.--Horse  (HRBC) and  sheep (SRBC) erythrocytes  in  Alsever's 
solution  (Grand Island Biological Co., Grand  Island,  N.Y.)  were washed three  times by 
centrifugation with 40 vol of sterile Hanks' balanced salt solution (HBSS) and resuspended 
in HBSS to 20 X  l0  s RBC/ml for use in the hemolytic plaque assay or 2.5 X  l0  s RBC/ml 
for use as antigen  in cultures. 
Preparation of Mydoma  Proteins and Anti-Immunoglobulin Sera.--Myeloma  proteins and 
fight chains were purified from ascitic fluid or urine from BALB/c mice bearing appropriate 
ascitic  plasma  cell tumors  by preparative  electrophoresis on  Geon/Pevikon  resin  blocks 
followed when needed by Sephadex G-200 filtration (Pharmacia Fine Chemicals Inc., Piscat- 
away, N.J.)  (52-54). Fc fragments were prepared by a modification of the method of Porter 
(54). Antiglobulins used for development of ~'G and TA PFC in the hemolytic plaque assay 
were prepared in rabbits and purified as described previously (52, 53). 
Antiglobulins for addition to mouse spleen cell cultures were raised in goats by repeated 
immunization with  the  immunogens listed in Table  I  incorporated  in complete Freund's 
adjuvant (54). Anti-ferritin was raised in goats by repeated immunization with horse spleen 
ferritin  (Pentex Biochemical, Kankakee, IlL) incorporated in complete Freund's adjuvant. 
All antisera,  myeloma protein, and light chain preparations  were decomplemented at 56°C 
for 30 min and absorbed twice with 1 ml each of washed, packed SRBC and HRBC/10 ml 
serum and once with  1 ml of washed, packed C57BL/6 spleen cells per  10 ml serum. The 
antisera were rendered specific by appropriate absorption with purified light chain, myeloma 
protein, or germfree mouse serum as indicated in Table I. Monospecifie  antiglobulins coupled 
a  Abbreviations used in this paper: "'yG" is used to refer to 3/1,7~, and T2b imnmnoglobu- 
lins in aggregate; HBSS, Hanks' balanced salt solution lacking sodium bicarbonate; HRBC, 
horse red  blood cells; Ig, immunoglobulin(s); LNC,  lymph  node cells; Me,  macrophages; 
MEM, minimal essential medium; PFC, plaque-forming cell(s); RBC, red blood cell; SRBC, 
sheep red blood ceils; -0LC, anti-0-treated lymphoid cells. c.  w.  PIERCE~  S.  M.  SOLLIDAY~ AND  R.  ASOFSKY  677 
to bromo-acetyl cellulose (55)  did not bind 125I-labeled  light chains or myeloma proteins of 
Ig  classes other than the one against which the antiglobulin was  directed.  Before addition 
to cultures, all reagents were sterilized by filtration through a  prewashed 0.45 /z Millipore 
filter  (Millipore Corporation,  Bedford,  Mass.) 
Preparation of AKR Anti-O C3H/He.--AKR  mice were  injected intraperitoneally with 
25  )<  10 ~ C3H/He  thymus cells  (56-58)  at  14-day intervals until the specific anti-0 titer 
against C3H/He  thymus cells 7  days after  the last immunization was  greater  than Yll000 
using 50% eytotoxicity as the end point. Normal and immunized mice were then bled and 
the serum was decomplemented, absorbed with SRBC and HRBC, and sterilized as described 
above.  The  specificity  of  the  anti-0 serum  for  only  0-bearing  cells  was  demonstrated  by 
cytotoxicity assays using either rabbit or guinea pig serum as complement, 51Cr-labeled cells 
TABLE  I 
Biological Reagents 
Antiglobulin  Immunogen  Absorbants  Speci=  ficity 
Anti-~  MOPC-104E myeloma protein  X-chain MOPC-104E 
urinary protein 
Anti-~'l  MOPC-31c  myeloma protein  --  "Y1 
Fc piece 
Anti-'y2  Adj PC-5  myeloma protein  --  "~.2 
Fc piece 
Anti-'yA  MPC-1 myeloma protein  Germfree serum  a 
Anti-K  Adj PC-9 urinary protein  --  K 
Anti-X  MOPC-104E urinary protein  --  X 
Myeloma protein  Immunoglobulin class 
MOPC-104E  qtM 
MPC-47, MOPC-70A, MOPC-31c  T1 
LPC-1, Adj PC-5  ~/2, 
MPC-11, MPC-37  "~'2b 
SPC-1, MPC 40, MPC-1  ~/A 
MOPC-104E urinary protein  X 
Adj PC-9 urinary protein  K 
from several lymphoid tissues (58),  and anti-0 serum appropriately absorbed with lymphoid 
tissues or brain. Anti-allotype (59) and anti-LyC2  (60) activities were not detected. 
Spleen Cell Cultures.--Single  cell suspensions of spleen were prepared  as  described pre- 
vously (52)  and were incubated in 35  X  10 mm plastic culture dishes (Falcon 3005 [Falcon 
Plastics, Div. of Bioquest, Oxnard, Calif.]) at a density of 10 )<  106 cells/1 ml in completely 
supplemented Eagle's minimal essential medium  (MEM)  (61), containing 10% fetal bovine 
serum  (Reheis Chemical Co., Kankakee, Ill., lots E21505, E21806), and 50 units each/ml of 
penicillin and mycostatin and 50 #g/ml of streptomycin, with or without antigen, 3-7 )<  106 
RBC/culture;  the incubations occurred  in a  water-saturated  atmosphere of  7%  02,  10% 
COs, and 83% N2 at 37°C in an airtight box on a rocking platform oscillating at 31~ complete 
cycles/rain.  Media  and  supplements  other  than  fetal  bovine  serum  were  obtained  from 
Microbiological Associates, Inc., Bethesda, Md. Cultures were supplemented daily with 0.05 
ml of a nutritional mixture and fetal bovine serum  (52).  Goat antiglobulins and anti-ferritin 
were diluted in HBSS and 0.05 ml were added to cultures as dictated by experimental protocol. 678  IMMUNE  RESPONSES  IN  VITRO.  IV 
Ceils were harvested after 5 or 7 days' incubation and washed once by centrifugation before 
assay for hemolytic PFC. 
Hemolytic Plaque Assay.--Ig class-specific  PFC from spleen cell cultures were enumerated 
by a modification of the Jerne hemolytic plaque (62) described in detail elsewhere (52). 3"M 
PFC were enumerated after incubation of indicator erythrocytes and  spleen cells in semisolid 
agarose in HBSS using guinea pig serum (Baltimore Biological Laboratories, Baltimore, Md.) 
as a complement source.  Ig class-specific  3'G and 3~A PFC were developed with monospecific 
or polyvalent rabbit antiglobulins and complement in assay preparations  to which sufficient 
goat anti-~z antibody had been added to inhibit development of all 3"M PFC. 
Cells recovered from culture dishes were counted with a Coulter Counter Model B (Coulter 
Electronics, Inc., Hialeah, Fla.); PFC were expressed  per 106 recovered cells or per culture. 
Data presented are from experiments with comparable cell recoveries in comparable  experi- 
mental groups.  In most graphs, data are expressed as per cent control response to allow com- 
parison of data from three to five experiments with identical protocol. Statistical analyses are 
not presented on each graph  since  the coefficient  of variability of experimental groups was 
always less than 15%. 
51Cr Cytotoxicity Assay.--Single cell suspensions  of mouse spleen,  thymus,  bone marrow, 
or lymph node  (50)<  106 cells/ml) in medium L-15  (Microbiological Associates, Inc.) with 
10% fetal bovine serum were freed of RBC by treatment with tris(hydroxymethyl)amino- 
methane-buffered  NH4Cl  and  labeled  with  Na2  51CrO4 as  described  by  Raft  and  Wortis 
(58). For the assay, 0.1 mt of 51Cr-labeled cells,  (5 X  106/ml), 0.1 ml of antiserum at desired 
concentration or medium, and 0.1 ml of a noncytotoxic complement source at predetermined 
optimal dilution  (lyophilized guinea pig serum  [Baltimore Biological Laboratories]  or fresh 
rabbit or mouse serum) or medium were incubated at 37°C for 1 hr in i0 X  75 mm glass tubes; 
0.7 ml of L-15 was added and the cells were sedimented by centrifugation; 0.5 ml of the super- 
nate was removed and counted in a Packard Autogamma Spectrometer (Packard Instrument 
Co., Inc., Downers Grove, Ill.). Controls for spontaneous release,  release due to complement 
alone as well as release from thrice-frozen and -thawed samples,  and samples incubated with 
appropriate  anti-H2  serum 2 were  included. 
RESULTS 
Effect  of Goat Antiglobulins  on Primary Ig Class-Specific PFC Responses In 
Vitro.--Cultures  of  C57BL/6  spleen  cells were  stimulated  with  SRBC  in  the 
presence  of goat  antibodies  against  the major heavy chains of mouse immuno- 
globulins, K- or k  light chains or ferritin. Ig  class-specific  PFC  responses were 
determined  after  5  days  of  incubation  and  compared  to  responses  in  control 
cultures  to  which  ilo goat serum was  added  (Fig.  1).  High concentrations  (50 
/zl, 1:10 dilution)  of anti-K, anti-X (not shown in Fig. 1),  or anti-ferritin had no 
effect on  any Ig  class-specific response;  anti-')'A suppressed  only  the "yA PFC 
response,  anti-3"1 or anti-3"2 each suppressed  both  the 3'1 and 3"2, but not 3"A or 
3'M responses.  Anti-/z suppressed  all Ig class-specific PFC  responses. 
Since anti-/z produced  the greatest  suppression,  and affected responses  of all 
Ig classes,  the specificity, mechanism,  and  site of action of this antiglobulin  in 
various experimental  situations was studied  in detail.  High concentrations  (50 
2Anti_H2  sera  were  obtained  from  Dr.  Donald  E.  Kayhoe,  Transplantation  and  Im- 
munology  Branch,  Collaborative  Research,  National  Institute  of  Allergy and  Infectious 
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/zl, 1:10 and 1:25 dilutions)  added at the initiation of the cultures profoundly 
suppressed the responses in all Ig classes (Fig. 2). However, at lower concentra- 
tions,  for example 50 #1  of the  1:1000  dilution,  anti-#  consistently  enhanced 
PFC  responses in all Ig classes. The degree of suppression by high concentra- 
tions of anti-/z was about equal in all  the Ig classes, but  enhancement varied 
from about 30% for 3"A responses to  100%  or more for 3"M  and 3"G responses. 
In the experiments shown in Fig.  1 and in the remaining figures, responses of 
control cultures were within 4-0.3 to 0.5 log units of those indicated in Fig. 2. 
Specificity of the Suppressive Activity of Anti-/z on PFC Responses In  Vitro.- 
The specificity of the  suppressing activitv of the anti-/z was demonstrated in 
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Fic.  1.  Effect of goat antiglobulins on primary Ig class-specific  PFC responses in vitro. 
Antiglobulins were added at initiation of cultures. Data are expressed as per cent of the re- 
sponse in each Ig class in cultures without any additives. Representative PFC responses per 
106 cells are shown in Fig. 2. 
two ways: first,  absorption  of anti-/z with 3"M  myeloma protein  insolubilized 
with ethylchloroformate (63)  removed virtually all suppressive activity (Fig. 3). 
Increased concentrations of this absorbed preparation of anti-# (50 #1, 1 : 5 dilu- 
tion) also had no suppressive activity. Similar absorption with insolubilized 3'1 
and 3'2 myeloma proteins had no measurable effect on the suppressive activity 
of the anti-#. Second, when myeloma proteins were added together with anti-/z 
at the initiation of the cultures, only 3"M myeloma protein neutralized or partly 
neutralized the suppressive activity of anti-/z; 3"G or 3"A myeloma had no effect 
on the suppressive activity of anti-/z (Fig. 4). The degree of reversal of anti-/z- 
mediated suppression produced by 50/zg of 3"M myeloma protein was depend- 
ent on the amount of anti-/z added to the cultures. Addition of 50/zg of 3"M, 3"G, 
or 3"A myeloma protein  to  control  cultures  had  no  effect on Ig class-specific 
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Effect of various concentrations of goat anti-/z on Ig class-specific PFC responses  FIG.  2. 
in vitro. Data are from a  representative experiment; PFC responses in all experiments were 
±  0.3 to 0.5 log units of those indicated. 
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Fro. 3.  Specificity of goat anti-/~ for/z-chain determinants: effect of absorption of anti-/~ 
with insolublized 3"M  or 3~G myeloma proteins on suppressive activity. 
None of the antiglobulins tested at any concentration had any cytotoxic ac- 
tivity for either 5~Cr-labeled thymus or spleen cells  in the absence or presence 
of complement sources that killed virtually 100 % of these cells in the presence 
of the appropriate anti-H2 antisera.  Also,  when spleen cells were labeled with C.  W.  PIERCE,  S.  M.  SOLLIDAY,  AND  R.  ASOFSKY  681 
~lCr and incubated in the culture  system with SRBC with or without anti-/*, 
51Cr release into the culture supernate was not increased in cultures to which 
anti-/* had been added,  but subsequent PFC  responses in these cultures were 
suppressed. 
Time Requirement for Excess  Anti-/* for Suppression  of PFC Responses  In 
Vitro.--To determine whether an excess of anti-/* was required in the cultures 
throughout the 5 days' incubation for suppression of PFC responses, cells from 
stimulated cultures both with and without anti-/* were harvested at 24-hr inter- 
vals after initiation of the cultures, washed twice by centrifugation with 50 vol 
of HBSS, and returned to the original culture dishes in 1 ml of fresh medium. 
Cells adhering to the dishes were also washed with HBSS. Thereafter, the only 
anti-/* in  the  system was that which had  remained bound  to cells.  When  the 
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FIG.  4.  Specificity of goat anti-# for/z-chain determinants: effect of adding 3'M, 3'G, or 
3'A myeloma proteins with anti-# on suppressive activity. Data from experiments with 1:25 
and 1:50 dilutions of anti-/z, as indicated by arrows, are shown. 
excess anti-/* was removed at 48 hr or later, PFC responses were suppressed to 
the same degree as responses in cultures where excess anti-/* was not removed 
until immediately before PFC assay at 120 hr (Fig. 5). Addition of 50/*g of 7M 
myeloma protein after removal of excess anti-/* at 48 hr had no effect on the 
5-day PFC responses. However, when excess anti-/, was removed at 24 hr, sup- 
pression of the 5-day PFC  responses was considerably less; responses in these 
cultures were about 50 % of responses in control cultures. The suppressive activ- 
ity was further reduced by addition of 50/*g of 7M myeloma protein, but not 
by 3,G myeloma proteins after removal of excess anti-/* at 24 hr. 
A similar experimental design was employed to determine if spleen cells,  after 
48  hr  exposure to an excess of anti-#,  were totally unresponsive  to  antigenic 
stimulation.  SRBC-stimulated cultures were incubated with or without anti-/* 
for 48 hr, excess anti-/* was removed by washing, and cultures were continued 
with no additions,  with addition  of 50 pg of 3,M  or ~G myeloma protein,  or 682  IMMUNE  RESPONSES  IN  VITRO.  IV 
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with 3-7  X  106 HRBC or SRBC with or without "yM or ~G myeloma protein. 
3'M and "yG PFC were enumerated on days 5 and 7. 
After removal of excess anti-#  at 48  hr,  cultures with no additions  had no 
increase in PFC  responses relative to controls when incubation was prolonged 
to 7 days. However, addition of 50 #g of 3'M myeloma protein at 48 hr, although 
it produced no dramatic effect by 5 days, did result in considerably increased 
responses  in  7-day cultures  (Fig.  6).  Addition  of fresh SRBC  alone at  48  hr 
produced only marginal increases in 5- and 7-day responses; however, addition 
of 3'M myeloma with the SRBC  resulted  in markedly increased responses by 
day 7. A primary response to a second antigen, HRBC, initiated when the excess 
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Effect on PFC responses in vitro of goat anti-# added after initiation of cultures. 
anti-/z was removed at 48 hr was about 50 % of the response in control cultures 
after 5 days' incubation with HRBC (7 days  total) ; addition  of 3'M myeloma 
protein with the HRBC further reduced the suppressive activity of the anti-# 
and responses in these cultures were about 75 % of control responses. "yG mye- 
loma protein had no effect alone and no additive effect when added with SRBC 
or HRBC. In experiments where the order of addition of HRBC and SRBC to 
the cultures was reversed, the results were similar. 
Effect of Anti-lz Added after Initiation of Spleen Cell Culture on PFC Responses 
In Vitro.--Anti-# may be blocking antigen receptors on precursor cells and thus 
preventing antigenic stimulation. If this were true, once stimulation of the pre- 
cursors had been achieved, anti-# should have no effect. The suppressive effect 
of anti-/~  was most pronounced when it was added at the initation  of the cul- 
tures  (Fig.  7).  Less suppression resulted when anti-/z was added at 24 hr with 684  IMMUNE  RESPONSES  IN  VITRO.  IV 
dispersion  of cell  clusters  in  the  cultures.  No significant  effect was  observed 
when anti-/~ was added at 48 hr. Paradoxically, an amount of anti-# which was 
suppressive when added at the initiation of the cultures (50 ~1, 1:25 dilution), 
significantly enhanced 3'M, 3'G, but not ~/A PFC responses when added to cul- 
tures at 72 hr. Anti-/, added at 96 hr or 30 rain before asay  at 120 hr  had  no 
significant effect. 
Effect of Antigen Dose on Suppressive  Activity of Anti-i~ on PFC Responses  In 
Vitro.--The effects of several dilutions of anti-~ on 3'M and 3'G PFC responses 
in cultures stimulated with 107, 105, or 10  ~ SRBC were compared. Antigen did 
not effectively compete with anti-# for antigen receptors (Fig. 8).  The degree 
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Effect of antigen dose on suppressive activity of goat anti-# on PFC responses in 
of suppression by each dilution of anti-b~ was almost identical at each SRBC 
dose for 3'M and 3'G responses. 
Duration of Exposure to Anti-~ Required  to Achieve Suppression  of PFC Re- 
sponses In  Vitro.--Before  the investigation of the site of action of anti-#, the 
duration of exposure of spleen cells to anti-~ in cultures without antigen neces- 
sary  to  achieve  suppression  of  a  subsequent  PFC  response  was  determined. 
Spleen cells were incubated with 50/~1 of a  1 : 10 dilution of anti-~ for various 
intervals, excess anti-# was removed by washing and cultures were then stimu- 
lated with SRBC; PFC responses were assayed 5 days after addition of antigen. 
Exposure of spleen cells to anti-# for 24 hr was necesarv to achieve reproducible 
suppression of both 3~M  and 3'G responses (Fig.  9). 3'M myeloma protein par- C.  W.  PIERCE,  S.  M.  SOLLIDAY,  AND  R.  ASOk'SKY  685 
tially reversed the suppression when added with the antigen. Shorter exposure 
to anti-# did not result in significant and reproducible suppression. 
Site of Action of Anti-tz in Suppression  of PFC Responses In Vitro.--Interac- 
tions  among  three functionally distinct  type of cells,  macrophages,  thymus- 
derived lymphocytes, and precursor lymphocytes, are required for development 
of PFC responses in vitro  3 (5, 6, 64-72). 
Macrophages (M~) were separated from spleen cell suspensions by adherence 
to the plastic culture dishes (72, 73) and freed of loosely adhering lymphoid cells 
by washing with HBSS. The nonadherent lymphoid cells from spleen (10  X 
106/ml) were treated with AKR anti-0 C3H (titer 1 : 1256, final dilution 1 : 20) 
and guinea pig complement (Baltimore Biological Laboratories, final dilution 
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FIG. 9.  Duration of exposure to goat anti-#  required to achieve suppression of sub- 
sequently stimulated cultures. 
1: 10)  to remove 0-positive, thymus-derived cells  (57,  58,  65). The lymphoid 
cells, antiserum, and complement were incubated at 37°C for 60 rain; cells were 
washed twice by centrifugation with 25 vol of HBSS. None of the cells remaining 
could be killed by anti-0 and complement; this population contains the precur- 
sors of antibody-forming cells and will  be referred to as -0LC  (anti-0-treated 
lymphoid cells). Axillary and inguinal lymph nodes were the source of thymus- 
derived cells and are referred to as LNC; 75-85 % of these cells were 0-positive. 
None of these partially purified cell populations when incubated alone or in 
combinations of any two cell types at cell densities indicated in Table II devel- 
oped 3'M  or 3'G PFC  responses greater than  those detected in  unstimulated 
3 Pierce, C. W., and B. M. Johnson. Immune responses  in vitro. VI. Cell interactions in the 
development of primary "I'M and ")'G plaque-forming  cell responses in vitro. Manuscript in 
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whole spleen cell cultures. Further details of preparation of these cell popula- 
tions and their interactions in development of 3"M  and 3"G  PFC responses in 
vitro  will  be  presented  elsewhere?  Cell  populations were  incubated with  or 
without anti-/* (50/*1,  l:10 dilution) for 24 hr and washed by centrifugation; 
cultures were reconstituted to 1 ml final volume as follows: M~ 1-2 X  105/dish; 
lymph node cells (LNC)  1.17>1.5 X  106/dish; -0LC 8.0-8.5  X  106/dish, and 1 
X  10  r SRBC. 
Cultures in which all three cell populations had been exposed to anti-/, or to 
which anti-/* (50/*1,  1 : 25 dilution) was added at reconstitution had suppressed 
"FABLE II 
Celhdar Requirements for Development of Primary TM and 3zG  PFC Responses In  Vitro 
Culture variables 
10 X  106 spleen cells 
1 X  105 Mq  ~ 
2 X  106 LNC 
8 X  106 --0LC 
1X  105M~+2 X  106LNC 
1 X  105M~+8  X  106-0LC 
2 X  106LNC  q-8X  106-0LC 
1 X  105M~--k2 X  106LNC 
+  8 X  106 --0LC 
1 X  105Mq  ~-k2 X  106LNC 
+  8 X  106 --0LC 
10 X  106 spleen cells 
q- SRBC 
+  SRBC 
+  SRBC 
-k- SRBC 
-b SRBC 
-k- SRBC 
+  SR]3C 
-k SRBC 
PFC/I0~; recovered cells--day  5 
i  -¢M  ~G 
Exp. l  Exp. 2  Exp. 3 Exp. 1  Exp. 2 Exp. 3 
840  1137  1417  360  420  463 
23  21  i  13  3  0  3 
]  10  13  29  0  0  7 
i  168  177  I  181  31  39  23 
13  171  13  1  2  0 
151 
169 
977 
133 
147 
183 
152 
1376 
141 
163 
140  33 
189  38 
1110  387 
179  30 
155  27 
50  21 
53  29 
516  444 
41  30 
49  37 
Cell populations are prepared  as described in the  text.  M6~  =  macrophages; LNC  = 
lymph node cells; --0LC  =  splenic lymphoid cells treated  with  anti-0 and complement; 
SRBC  =  3-7  X  106 sheep erythrocytes. 
responses (Fig.  10). However, cultures in which only M~ or LNC  or both of 
these cell types had been exposed to anti-# were not suppressed. Cultures with 
anti-/*  treated -0LC or precursors had suppressed responses which were partially 
restored by addition of ~,M, but not 3"G myeloma protein at the time of recon- 
stitution. 
DISCUSSION 
These  experiments demonstrate that goat  anti-mouse /*-chain antibody al- 
most  completely suppresses primary PFC  responses of  3"M, 3"G, and 3,A  Ig 
classes in mouse spleen cell cultures, whereas anti-3"1 or anti-3,2 suppress both 
3'1 and 3'2, but not 3"M  or 3"A PFC responses, and anti-2/A suppresses only 3"A c.  w.  PIERCE~ S.  M.  SOLLIDAY, AND  R.  ASOFSKY  687 
responses. The degree of suppression by anti-/~ is dependent on the amount  of 
anti-/z added to the culture, and the time at which it is added. The anti-/~ chain 
serum was highly specific for/~-chain determinants: Suppressive activity was 
eliminated by absorption with insolubilized -yM myeloma protein, but not with 
similarly treated ~,G myeloma proteins; further,  this suppressive activity was 
inhibited competitively by "yM myeloma protein  in  solution,  but  not  by qcG 
or  "yA  proteins. The activity of  anti-# was not the result of a  cytotoxic effect; 
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FIG. 10.  Cellular site of action of goat anti-# in suppression  of PFC responses. Macro- 
phages  (M(I,), lymph node  cells, as a  source  of thymus-derived cells  (LNC), and  anti-0- 
treated spleen lymphoid cells as a source of precursors of antibody-forming cells (-0LC) were 
prepared as described in the text, and incubated with (#)  or without (N) anti-# for 24 hr. 
Cultures were then reconstituted with 1-2  X  105 M~/dish,  1.0-1.5  X  106 LNC/dish, and 
8.0-8.5  X  106 -0LC/dish and l0  T SRBC. Cell populations alone or in any combination of two 
gave no response. 
anti-~ was  not cytotoxic alone or in the presence of a  variety of complement 
sources,  as judged by 51Cr release from labeled spleen or thymus cells. 
More compelling evidence for lack of cytotoxicity was obtained in studies of 
spleen cell function after anti-/z was removed from the culture system. Spleen 
cells incubated in, then  separated from medium containing anti-/z after 48  hr 
responded to new antigen, SRBC, or HRBC, if the culture period was prolonged 
to  7  days.  Addition of  ~/M  myeloma protein  together with  the  new  antigen 
improved the response, indicating that  anti-/z bound  to the cells could be en- 
ticed from the cell surfaces by excess TM protein in solution. This phenomenon 688  IMMUNE  RESPONSES  IN  VITRO.  IV 
was also observed in experiments assayed after 5 days' incubation with antigen 
in which the suppression produced by incubation of spleen cells with anti-/* for 
24 hr was partially reversed by addition of 3'M myeloma protein after removal 
of excess anti-/,. The experiments in which anti-/* was added at 24 hr-intervals 
after initiation of the cultures also demonstrated lack of nonspecific cytotoxicity 
of this reagent, but more importantly provided strong evidence that stimulation 
of precursor cells by antigen is completed by 48 hr. At this time or later, anti-/* 
no longer had a suppressive effect, suggesting that the event(s) with which it 
interfered when added earlier in the response was completed. In fact, when the 
normally suppressive amount of anti-/* was added at 72 hr after initiation of the 
cultures, 3"M and 3'G responses were significantly enhanced. This enhancement 
may be due to neutralization of an early, regulatory ~,M antibody, which nor- 
mally modulates responses, as has been suggested previously (52), or to a mito- 
genic effect of the  anti-/*  on stimulated  precursor cells with  surface/*-chain 
determinants which results in an expansion of this clone of cells. These possibil- 
ities are currently being investigated. 
Another observation deserves comment at this juncture: Effective suppres- 
sion of PFC responses requires incubation of spleen cells with anti-/* for 24 hr 
or longer. Brief exposures, which should have been sufficient for anti-/* to com- 
bine with/*-chain determinants in receptors, resulted in only marginal suppres- 
sion. The mechanism of suppression by anti-/* appears to be more complex than 
simply the saturation of Ig receptors and prevention of antigenic stimulation. 
Perhaps a time-dependent phenomenon, such as endocytosis of an anti-Ig-cell 
surface Ig complex (74, 75), which results in removal of Ig from the cell surface 
plays a part in the suppression. Whatever the explanation, these Ig receptors 
probably can no longer be considered as static membrane structures, but must 
be considered in terms of their kinetics and mobility in the cell membrane. 
Unlike soluble ~M protein, increased numbers of erythrocytes added to the 
cultures proved incapable of overcoming the suppressive effect of anti-/*.  It is 
possible that the anti-/* had a greater affinity for the receptor than did the anti- 
gen. It is also conceivable that it is impossible to raise the effective antigen dose 
sufficiently to overcome the effects of anti-/*.  In this context, it is worth noting 
that the dose-response curve for SRBC in mouse spleen cell cultures is quite flat; 
an increase in the dose of antigen from 10  a to 107 RBC,/culture produces only a 
10- to 20-fold increase in PFC responses (52, 73). 
The data indicate that the suppressive effect of anti-/*  is mediated through 
the precursor lymphocytes. These cells have surface Ig molecules (25-27) which 
in the mouse are  largely of the "yM class (17,  35).  Thus,  the  combination of 
anti-/* with/*-chain determinants in ~,M receptors for SRBC  and the effective 
saturation of or interference with the function of these receptors would prevent 
stimulation of these cells by antigen and suppress subsequent antibody produc- 
tion. The data do not preclude the existence of/*-chain determinants on thymus- 
derived lymphocytes as has been  reported  (42);  they only indicate  that  the C.  W.  PIERCE,  S.  M.  SOLLIDA¥,  AND  R.  ASOFSK¥  689 
suppression of PFC responses by anti-/~ is not mediated through/~-chain deter- 
minants in receptors in thymus-derived cells. 
The class of the surface Ig receptor on the precursor cell has been thought to 
represent the Ig class of the antibody that will be produced by that cell after 
antigenic stimulation (29, 32, 38, 42, 44, 46  48) : The prediction that saturation 
of Ig class-specific receptors on precursor cells by antiglobulin would result in 
suppression  of  the  antibody  response in  only that  Ig class was not  verified, 
especially in the case of anti-/~. The prediction was strictly correct only for anti- 
3"A which  suppressed only 3"A responses. Although  anti-3"1 or anti-3"2 did not 
suppress 3"A or 3'M  responses,  either  reagent  suppressed  both 3'1 and 3'2 re- 
sponses. This cross inhibition may be due to cross-reacting antibodies  in  the 
reagents  that went undetected  in conventional  assay methods. However, the 
possibility that the cells capable of synthesizing 3"1 or 3".2 antibodies have both 
3"1 and 3"2 receptors present on the same cell must be considered (25). 
Mouse spleen lymphocytes have 3"- and a-determinants in immunoglobulin 
receptors on their surfaces (11,  12,  25-27). This might account for the ability 
of antiglobulins  to  suppress  responses in  these  classes without  affecting 3"M 
responses; it also lends support to the concept that sometimes the surface Ig is 
of the same class as the antibody later to be secreted. However, cells with  3"- 
or a-determinants may have arisen by a previous encounter with a closely re- 
lated antigenic  determinant  and may reflect remnants of a  memory cell pool 
remaining in the "experimentally virgin beast." 
The lack of effect of anti-K in the present experiments is most likely due to 
the quality of this reagent, since other investigators using anti-K without com- 
plement have successfully inhibited PFC responses in vitro (49). Experiments 
in which  anti-IgG was used  to inhibit 3"M  PFC  responses were undoubtedly 
successful  due  to antibody activity to common Ig determinants  in  the poly- 
valent reagents (42,  50,  51).  Similarly, failure of anti-Fc reagents to suppress 
3"M PFC responses is probably related to the fact that the anti-Fc was directed 
against 3"2a Fc determinants  and not 3"M Fc.  Effects on 3"2a class-specific re- 
sponses were not reported (50). 
There are several possible explanations for the observation that anti-/z sup- 
presses 3"G and 3"A as well as 3`M PFC responses; all are related to the Ig recep- 
tors on virgin precursor cells since the demonstrated site of action of the anti-# 
is on this cell population and not on thymus-derived lymphocytes. 
Precursor cells may have many receptors in close proximity on their surfaces, 
some with/~-determinants, others with 3"- or a-determinants. Blocking the func- 
tion of the receptor with the/~-chain determinant may, due to steric hindrance, 
also prevent antigen binding to receptors with 3'- and a-determinants and sub- 
sequent stimulation of these cells. This explanation is unlikely since anti-3"1, -3'2, 
or -3"A reagents did not cause suppression of all Ig class-specific responses, which 
would be expected, by analogy, if steric factors alone were important in suppres- 
sion by anti-/~.  However, such steric factors may help explain suppression  of 690  IMMUNE  RESPONSES  IN  VITRO.  IV 
both 3`t and 3'2 PFC responses with either anti-71 or anti-3,2 reagents if 3'1 and 
3"2 receptors are represented on the same cell surfaces in close proximity. 
3`G and 3`A PFC might arise by direct conversion  from cells secreting 3`M anti- 
body earlier in the immune response. Inhibition of 3`M PFC development by 
anti-/z would preclude 3"G or 3'A PFC development. Studies in which conversion 
from yM to 3`G antibody secretion were reported indicate that this is a limited 
event of such low frequency that numbers of observed "/G PFC cannot all have 
arisen by direct conversion (76-78). 
Antibody-forming cell precursors may be precommitted to synthesis of 3,M, 
3`G, or 3"A antibody and bear surface receptors of only that Ig class. Stimulation 
of precursors with ~,M receptors might be a necessary and  integral step in the 
stimulation and development of precursors with 3'G or 3`A receptors into PFC. 
This implies,  however, some necessary interaction of antigen-stimulated 3'M 
precursors with ~G or 3,A precursors for complete stimulation of these latter 
precursor cells into antibody-secreting cells.  The data presented here do not 
exclude this possibility. However, such a model complicates the cell interaction 
scheme currently in vogue for development of humoral antibody responses to a 
four-cell model and restricts humoral immune responses to always having 3`M 
antibody production or at  least  stimulation  of yM  antibody-producing  cell 
precursors  as  a  necessary condition for stimulation  of yG  or 3"A  precursor 
ceils.  Data presented in  the  accompanying paper  suggest that  such  a  model 
is unlikely (79). 
Virgin precursor cells with 3"M receptors may not be precommitted to syn- 
thesis of antibody of a given Ig class and could conceivably differentiate to syn- 
thesize 3"M, ")'1, 3"2, or 3"A antibody, depending on as yet unknown factors opera- 
tive at the time of stimulation of the precursor cell by antigen. Suppression of 
all Ig class-specific responses by anti-/~ is readily explained in this model. How- 
ever, some indirect evidence may be interpreted to support the concept that 
precursor cells are precommitted to synthesis of antibodies of only one Ig class 
(28, 46, 48, 80, 81) ; analysis of surface receptors in these cells is incomplete, but 
3"M has been shown to be the predominating surface Ig on spleen lymphocytes 
(17, 25, 35). Thus a precursor cell with a 3"M receptor might have differentiated 
without antigenic stimulation, but under other selective pressures,  into a  cell 
capable of, for example, only 3"1 antibody synthesis. In this model, too, supres- 
sion of responses in all Ig classes by anti-** is easily explained.  Recent studies 
in germfree mice treated from birth with goat anti-/~ demonstrated that these 
mice had fewer lymphocytes with surface Ig of any class, depressed Ig synthesis 
in vitro in all classes  and no humoral  antibody response  to ferritin (82). The 
data were interpreted to indicate that  anti-v directly suppressed development 
of precursor lymphocytes and that cells ultimately committed  to synthesis of 
71, 3"2, or 3"A Ig were derived from cells which expressed 3"M determinants at an 
earlier stage  of differentiation. However, suppression  of  3"G or 3"A responses 
with  anti-3"1, anti-3`2,  or  anti-'yA  reagents  is  not  readily  explained  in  these 
models. C.  W.  PIERCE,  S.  M.  SOLLIDAY,  AND  R.  ASOFSKY  691 
It is conceivable that precursor cells precommitted to 3'1, 3'2, or 3"A antibody 
synthesis already have receptors of that Ig class in addition to 3"M receptors, 
or develop receptors of that Ig class after antigenic stimulation. Stimulation of 
precursors with both 3"M and 3"G or 3"A receptors might require antigen binding 
to both receptors. Or, where 3'G or 3'A receptors appear after antigenic stimula- 
tion via the 3"M receptor, antigen binding to the second receptor may be neces- 
sary for actual antibody synthesis and secretion; failure to bind antigen by the 
second receptor may be the mechanism of generation of memory cells. Anti-# 
by reaction with  the 3"M receptor common to all  precursors could suppress 
responses in all Ig classes, whereas other antiglobulins would effect 3"A or 3"G, 
but not 3"M responses. Although determinants of two heavy chain classes have 
not been directly denmnstrated on lymphocyte membranes, recent studies sug- 
gest this might be possible (25,  28, 83). Thus, during the development of 3"G 
or 3"A antibody-producing cells in a primary response, it appears that for some 
interval the precursors of these cells must display the Ig class later to be se- 
creted  as  an Ig receptor in  addition  to a  3"M receptor. After immunization, 
however, clones of precursor cells appear whose 3"G responses in vitro are not 
markedly suppressed by anti-~,  but are  suppressed by anti-3"1 or anti-3"2. Im- 
munization appears to generate changes in the class of Ig receptors on certain 
precursor cell populations; the kinetics of these cell populations suggest that 
they represent memory cell pools of 3"1 and 3"2 antibody-producing cell pre- 
cursors.  Subsequent  antigenic  stimulation  of  these  cells  may  be  mediated 
primarily through receptors of 3"1 or 3"2 Ig classes and not through receptors of 
the 3"M class (79). 
Whether cells bearing 3"M receptors are precommitted or not to synthesis of 
other Ig classes,  and whether or not receptors of two Ig classes are present on 
some virgin precursor cells,  the finding that anti-/z suppresses development of 
PFC of all Ig classes raises certain obvious questions. First, are 3"M receptors 
restricted to precursor cells present before stimulation with  antigen; second, 
does immunization produce changes in the precursor cell population with re- 
spect to its susceptibility to suppressive antiglobulins specific for different Ig 
classes; and third, are such changes, if present, permanent? The accompanying 
paper describes an investigation of these questions (79). 
SUMMARY 
The  suppressive  effects of  monospecific goat anti-mouse globulins on  pri- 
mary  immunoglobulin  class-specific plaque-forming  cell  responses  in  mouse 
spleen cell cultures were investigated. Anti-/z suppressed responses in all immu- 
noglobulin classes,  whereas  anti-3"1 and  anti-3"2 suppressed  the 3`1 and 3`2 re- 
sponses but not 7M or 3,A responses, and anti-TA suppressed only 3`A responses. 
The mechanism of action of the anti-/z was studied in detail because of its sup- 
pression of responses in all immunoglobulin classes. 
The  anti-/z  was  specific  for  /z-chain  determinants;  its  activity  was  dose 
dependent, but was not mediated by killing cells with surface/z-chain deter- 692  IMMUNE  RESPONSES  IN  VITRO.  IV 
minants.  Free 7M  but not 7G myeloma proteins in solution effectively com- 
peted with #-bearing cells for the anti-/~. An excess of anti-/z  was necessary in 
the cultures for 48 hr to insure complete suppression of 5-day responses.  How- 
ever, after removal of excess anti-# at 48 hr, responses could be stimulated by 
newly added  antigen  in  cultures  where  incubation was prolonged to  7 days. 
Anti-/z  was most effective when added at the initiation of cultures and had  no 
suppressive effect when added at 48 hr. Excess antigen did not effectively com- 
pete with anti-/z for antigen receptors. Precursors of antibody-forming cells were 
shown to be  the cell  population where  the  suppressive  activity of anti-/z  was 
mediated. 
The experiments suggest that anti-/z  combines with/z-chain deternIinants in 
antigen-specific receptors on the surfaces of antibody-forming cell  precursors, 
prevents effective stimulation by antigen and subsequent antibody production. 
To explain suppression of responses in all Ig classes  by anti-/z,  several models 
were proposed. It is not possible to determine from the data whether stimulation 
of precursor cells with TG or 7A receptors requires concommitant stimulation 
of separate cells with only 3'M receptors, or whether cells bearing 3,M receptors 
are precommitted to or differentiate into cells capable of synthesis of other Ig 
classes,  or whether receptors of 7M  and another Ig class are present  on some 
virgin precursors or the second Ig receptor appears after antigenic stimulation. 
We thank Dr. Baruj Benacerraf for encouragment and advice during the course of these 
experiments. 
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